Compared with placebo, GLP-1RAs treatment in T2DM patients significantly reduced the risk of death from cardiovascular disease and fatal/non-fatal stroke in cardiovascular outcome trials (Qin and Song, 2022)
With respect to limitations, although the study was sufficiently powered to detect significant effects, the sample was small, limited to females, and predominantly White and non-Hispanic, which restricts the generalizability of the findings
Why Medical Weight Loss Is Different From Traditional Dieting Many people begin their weight-loss journey with the assumption that success depends entirely on willpower
Body composition tracking is the third lever
Nyquil, especially because of the acetaminophen it contains, can also irritate the stomach in some users